Abstract
The potential of alkaline 2 % glutaraldehyde solutions, with and without surface active agents, to alter the antigenicity of hepatitis B virus (HBV) was analyzed and compared to the antigenic alternation capacities of 0.525 % sodium hypochlorite and 2.02 % formaldehyde solutions. After treatment of a hepatitis B surface antigen-positive plasma at room temperature for 10 min, there was a 51–67 % reduction in surface antigen level and a 90–94 % decrease in hepatitis B core antigenicity. Glutaraldehyde is proposed as an alternative to the more noxious hypochlorite and formaldehyde solutions for disinfection of HBV-contaminated articles.
Similar content being viewed by others
References
Stonehill, A. A., Krop, S., Borick, P. M.: Buffered glutaraldehyde: a new chemical sterilizing solution. American Journal of Hospital Pharmacy 1963, 20: 458–465.
Collins, F. M., Montalbine, V.: Mycobactericidal activity of glutaraldehyde solutions. Journal of Clinical Microbiology 1976, 4: 408–412.
Miner, N. A., McDowell, J. W., Wilcockson, G. W., Bruckner, N. I., Stark, R. L., Whitmore, E. J.: Antimicrobial and other properties of a new stabilized alkaline glutaraldehyde disinfectant/sterilizer. American Journal of Hospital Pharmacy 1977, 34: 376–382.
Klein, M., DeForest, A.: Antiviral action of germicides. In: Borich, P. M. (ed.): Chemical sterilization. Dowden, Hutchinson & Ross, Stroudsburg, 1973, p. 188–191.
Alter, H. J.: Hepatitis B surface antigen and the health care professions. In: Greenwalt, T. J., Jamieson, G. A. (ed.): Transmissible disease and blood transfusion. Grune and Stratton, New York, 1975, p. 115–123.
Feldman, R. E., Schiff, E. R.: Hepatitis in dental professionals. Journal of the American Medical Association 1975, 232: 1228–1230.
Szmuness, W., Prince, A. M., Grady, G. F., Mann, M. K., Levine, R. W., Friedman, E. A., Jacobs, M. J., Josephson, A., Ribot, S., Shapiro, F. L., Stenzel, H. K., Suki, W. N., Vyas, G.: Hepatitis B infection. A point prevalence study in 15 U.S. hemodialysis centers. Journal of the American Medical Association 1974, 227: 901–906.
Robinson, W. S.: DNA and DNA polymerase in the core of Dane particles of hepatitis B. American Journal of Medical Science 1975, 270: 151–159.
Ling, C. M., Overby, L. R.: Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with125I-antibody. Journal of Immunology 1972, 109: 834–841.
Purcell, R. H., Gerin, J. L., Almeida, J. B., Holland, P. V.: Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology 1973/74, 2: 231–243.
Fields, H. A., Dreesman, G. R., Hollinger, F. B., Marciano-Cabral, F., Gyorkey, F., Melnick, J. L.: Endogenous DNA polymerease-positive core particles from hepatitis-infected hepatocytes. Intervirology 1975/76, 2: 224–238.
Greenwood, F. C., Hunter, W. M., Glover, J. S.: The preparation of125I-labelled human growth hormone of high specific radioactivity. Biochemical Journal 1963, 89: 114–123.
Hopwood, D., Allen, C. R., McCabe, M.: The reactions between glutaraldehyde and various proteins. An investigation of their kinetics. Histochemical Journal 1970, 2: 137–150.
Munton, T. J., Russell, A. D.: Aspects of the action of glutaraldehyde onEscherichia coli. Journal of Applied Bacteriology 1970, 33: 410–419.
Rubbo, S. D., Gardner, J. F., Webb, R. L.: Biocidal activities of glutaraldehyde and related compounds. Journal of Applied Bacteriology 1967,30:78–87.
Thomas, S., Russell, A. D.: Temperature-induced changes in the sporicidal activity and chemical properties of glutaraldehyde. Applied Microbiology 1974, 28: 331–335.
Thomas, S., Russell, A. D.: Studies on the mechanisms of the sporicidal action of glutaraldehyde. Journal of Applied Bacteriology 1974, 37: 83–92.
Gorman, S. P., Scott, E. M.: An assessment of the antifungal activity of glutaraldehyde. Journal of Pharmacy and Pharmacology 1976, Supplement, 28: 48P.
Spaulding, E. H.: Chemical disinfection and antisepsis in the hospital. Journal of Hospital Research 1972, 9: 5–31.
Richards, F. M., Knowles, J. R.: Glutaraldehyde as a protein cross-linking reagent. Journal of Molecular Biology 1968, 37: 231–233.
Korn, A. H., Feairheller, S. H., Filachione, E. M.: Glutaraldehyde: nature of the reagent. Journal of Molecular Biology 1972, 65: 525–529.
King, J. A., Woodside, W., McGucken, P. V.: Relationship between pH and antibacterial activity of glutaraldehyde. Journal of Pharmaceutical Sciences 1974, 63: 804–805.
Munton, T. J., Russell, A. D.: Effects of glutaraldehyde on the outer layers ofEscherichia coli. Journal of Applied Bacteriology 1972, 35: 193–199.
McGucken, P. V., Woodside, W.: Studies on the mode of action of glutaraldehyde onEscherichia coli. Journal of Applied Bacteriology 1973, 36: 419–426.
Hirschman, S. Z., Gerber, M., Garfinkel, E.: Purification of naked intranuclear particles from human liver infected with hepatitis B virus. Proceedings of the National Academy of Sciences, USA, 1974, 71: 3345–3349.
Almeida, J., Rubinstein, D., Scott, E. J.: A new antigen-antibody system in Australia-antigen positive hepatitis. Lancet 1971, 2: 1225–1227.
Baas, E. U., Baumeister, H. G.: Structural changes of Dane particles after treatment with disinfectants. Verhandlungen der Deutschen Gesellschaft für innere Medizin 1977, 83: 582–585.
Bond, W. W., Petersen, N. J., Favero, M. S.: Viral hepatitis B: aspects of environmental control. Health Laboratory Science 1977, 14: 235–252.
Krugman, S., Giles, J. P., Hammond, J.: Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. Journal of Infectious Diseases 1970, 122: 432–436.
Frösner, G., Jentsch, G., Uthemann, H.: Destroying of antigenicity and influencing the immunochemical reactivity of hepatitis B virus antigens (HBsAg, HBcAg, HBeAg) through disinfectants — a proposed method for testing. Zentralblatt für Bakteriologie Hygiene 1982, 176: 1–14.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adler-Storthz, K., Sehulster, L.M., Dreesman, G.R. et al. Effect of alkaline glutaraldehyde on hepatitis B virus antigens. Eur. J, Clin. Microbiol. 2, 316–320 (1983). https://doi.org/10.1007/BF02019460
Issue Date:
DOI: https://doi.org/10.1007/BF02019460